Thomas M. Kuntz

2 articles listing Thomas M. Kuntz in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial Nature Communications
2. Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS) Nature Communications